A drug already approved for osteoporosis blocked the mineral buildup that develops in the spines of zebrafish bred without a working copy of a collagen-related gene, researchers report.
The fish are the finding. They are a model of a specific genetic defect linked to early-onset spinal disc problems in humans, and every result here comes from them rather than from patients.
